Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Magnoni

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
International Journal of Cardiology|May 22, 2021
Metabolomic correlates of coronary atherosclerosis, cardiovascular risk, both or neither. Results of the 2 × 2 phenotypic CAPIRE studyMartino Deidda, Antonio Noto, Christian Cadeddu Dessalvi, et al.
International Journal of Cardiology|November 20, 2021
Mannose as a biomarker of coronary artery disease: Angiographic evidence and clinical significanceEle Ferrannini, Nikolaus Marx, Daniele Andreini, et al.
JACC. Cardiovascular Imaging|January 19, 2016
Reduction of Circulating HLA-DR<sup>+</sup> T Cell Levels Correlates With Increased Carotid Intraplaque Neovascularization and Atherosclerotic BurdenEnrico Ammirati, Marco Magnoni, Francesco Moroni, et al.
Diabetes Care|January 23, 2021
Erratum. Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study. Diabetes Care 2020;43:843-851Giulia Ferrannini, Maria Laura Manca, Marco Magnoni, et al.
Diabetes Care|January 29, 2020
Coronary Artery Disease and Type 2 Diabetes: A Proteomic StudyGiulia Ferrannini, Maria Laura Manca, Marco Magnoni, et al.
Metabolites|February 25, 2022
Why Do High-Risk Patients Develop or Not Develop Coronary Artery Disease? Metabolic Insights from the CAPIRE StudyMartino Deidda, Antonio Noto, Christian Cadeddu Dessalvi, et al.
The International Journal of Cardiovascular Imaging|April 26, 2026
CAPIRE score predicts long-term major cardiac eventsDaniele Andreini, Edoardo Conte, Marco Magnoni, et al.
The American Journal of Cardiology|March 16, 2016
Usefulness of High-Sensitivity Cardiac Troponin T for the Identification of Outlier Patients With Diffuse Coronary Atherosclerosis and Low-Risk FactorsMarco Magnoni, Serge Masson, Daniele Andreini, et al.
American Heart Journal|February 28, 2016
Coronary atherosclerosis in outlier subjects at the opposite extremes of traditional risk factors: Rationale and preliminary results of the Coronary Atherosclerosis in outlier subjects: Protective and novel Individual Risk factors Evaluation (CAPIRE) studyMarco Magnoni, Daniele Andreini, Marco Gorini, et al.
Atherosclerosis|October 19, 2016
Circulating CD14+ and CD14<sup>high</sup>CD16- classical monocytes are reduced in patients with signs of plaque neovascularization in the carotid arteryEnrico Ammirati, Francesco Moroni, Marco Magnoni, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
International Journal of Cardiology|May 22, 2021
Metabolomic correlates of coronary atherosclerosis, cardiovascular risk, both or neither. Results of the 2 × 2 phenotypic CAPIRE studyMartino Deidda, Antonio Noto, Christian Cadeddu Dessalvi, et al.
International Journal of Cardiology|November 20, 2021
Mannose as a biomarker of coronary artery disease: Angiographic evidence and clinical significanceEle Ferrannini, Nikolaus Marx, Daniele Andreini, et al.
JACC. Cardiovascular Imaging|January 19, 2016
Reduction of Circulating HLA-DR<sup>+</sup> T Cell Levels Correlates With Increased Carotid Intraplaque Neovascularization and Atherosclerotic BurdenEnrico Ammirati, Marco Magnoni, Francesco Moroni, et al.
Diabetes Care|January 23, 2021
Erratum. Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study. Diabetes Care 2020;43:843-851Giulia Ferrannini, Maria Laura Manca, Marco Magnoni, et al.
Diabetes Care|January 29, 2020
Coronary Artery Disease and Type 2 Diabetes: A Proteomic StudyGiulia Ferrannini, Maria Laura Manca, Marco Magnoni, et al.
Metabolites|February 25, 2022
Why Do High-Risk Patients Develop or Not Develop Coronary Artery Disease? Metabolic Insights from the CAPIRE StudyMartino Deidda, Antonio Noto, Christian Cadeddu Dessalvi, et al.
The International Journal of Cardiovascular Imaging|April 26, 2026
CAPIRE score predicts long-term major cardiac eventsDaniele Andreini, Edoardo Conte, Marco Magnoni, et al.
The American Journal of Cardiology|March 16, 2016
Usefulness of High-Sensitivity Cardiac Troponin T for the Identification of Outlier Patients With Diffuse Coronary Atherosclerosis and Low-Risk FactorsMarco Magnoni, Serge Masson, Daniele Andreini, et al.
American Heart Journal|February 28, 2016
Coronary atherosclerosis in outlier subjects at the opposite extremes of traditional risk factors: Rationale and preliminary results of the Coronary Atherosclerosis in outlier subjects: Protective and novel Individual Risk factors Evaluation (CAPIRE) studyMarco Magnoni, Daniele Andreini, Marco Gorini, et al.
Atherosclerosis|October 19, 2016
Circulating CD14+ and CD14<sup>high</sup>CD16- classical monocytes are reduced in patients with signs of plaque neovascularization in the carotid arteryEnrico Ammirati, Francesco Moroni, Marco Magnoni, et al.
Pageof 6